The drugmaker said Tuesday that it would stop studying danuglipron after a participant in one of its trials experienced a ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea in a late-stage clinical trial, according to ...

Pfizer is stopping development of its experimental oral GLP-1 drug for obesity, the company announced Monday, after a patient ...

A pill developed by GSK was found to be safe and effective in treating gonorrhea. It could be the first new type of ...

Pfizer is facing another setback with its weight-loss pill, danuglipron. The pharmaceutical giant stopped development of the ...

Pfizer said on Monday it has discontinued development of experimental weight-loss pill danuglipron after a trial patient ...

A new antibiotic could zap super gonorrhoea, a treatment-resistant strain of the STI which is increasing in the UK.

The announcement adds to a string of setbacks in Pfizer’s bid to win a slice of the booming market that Wall Street projects ...